Clinical Trials Directory

Trials / Completed

CompletedNCT04974853

Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation

Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation: Feasibility Study on Patients With Mild-to-moderate Hypercholesterolemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
NMP Medical Research Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this feasibility study was to assess the lipid-lowering effects and safety of a Ayurveda formulation containing Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer)

Detailed description

The COVID-19 related lockdowns severely affected the healthcare in India, specially in second wave of COVID-19. This research presents the applicability of Ayurveda formulation to analyze the impact on lipid profile during the lockdown. Patients with hyperlipidemia who referred to Gyansanjeevani were recruited. All participants were enrolled in the study after a complete physical examination and medical history remotely over the virtual secure platform.

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTCardio-complementAyurvedic combination of Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer) in pre-specified dosage.

Timeline

Start date
2021-06-01
Primary completion
2021-06-30
Completion
2021-07-05
First posted
2021-07-23
Last updated
2021-07-23

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04974853. Inclusion in this directory is not an endorsement.